Glycopyrrolate Injection
Product Images NDC 0143-9682

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 0143-9682). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Glycopyrrolate Injection 1)

It appears to be a chemical compound's formula including the molecular weight.*

FDA Label Image

Glycopyrrolate Injection 10

This is a product identification label that contains a Global Trade Item Number (GTIN) of 0301234567896, a Serial Number (SN) of 1234567890123, an expiration date (EXP) of MMMYYYY, and a lot number (LOT) of ABCDE12345.*

FDA Label Image

Ndc 0143-9682-01 Glycopyrrolate Injection, Usp 0.2 mg/ml Rx Only Contains Benzyl Alcohol For Im Or Iv Use 1 mL Single Dose Vial (Glycopyrrolate Injection 2)

This is a pharmaceutical product with the National Drug Code (NDC) 0143-682-01, which is available only through prescription. It is an injection solution with a strength of 0.2mg/mL that is intended for intramuscular or intravenous use. The solution comes in a 1mL single-dose vial and contains benzyl alcohol. The manufacturer of this solution is Hikma Pharmaceuticals, and it has been assigned the lot number PLBG4-WES 2. However, the expiration date is not available as the last line is incomplete.*

FDA Label Image

Ndc 0143-9682-25 Glycopyrrolate Injection, Usp 0.2 mg/ml Rx Only Not For Use In Newborns Contains Benzyl Alcohol For Im Or Iv Administration 25 X 1 mL Single Dose Vials (Glycopyrrolate Injection 3)

This is a description of an injectable solution contained in a single dose vial. The solution is indicated for intramuscular or intravenous use and contains water for injection, USP, as well as 0.9% benzyl alcohol, NF (preservative). The solution is pH adjusted with hydrochloric acid and/or sodium hydroxide as necessary. The usual dosage is determined by the package insert. The solution is not for use in newborns and should be stored at the temperature of 20° to 25°C (68° to 77°F). The NDC number is 0143-9682-25 and the product is distributed by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Ndc 0143-9680-01 Rx Only Glycopyrrolate Injection, Usp 1 mg/5 mL (0.2 mg/ml) Not For Use In Newborns Contains Benzyl Alcohol For Im Or Iv Adminisration 5 mL Multiple Dose Vial (Glycopyrrolate Injection 4)

Glycopyrrolate Injection is indicated for M or IV use and it contains benzyl alcohol. Each 5 mL of the injectable solution contains 1 mg of glycopyrrolate. The solution is made with Water for Injection, USP and 0.9% Benzyl Alcohol, NF as preservative. The pH of the solution is adjusted as required. The usual dosage instruction is provided in the package insert. The solution comes in a 5 mL Multiple Dose Vial that is recommended to be stored at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature. Hikma distributes the product with a label number of (01) 00301439680017 and code PLB64G-WES/2.*

FDA Label Image

Ndc 0143-9680-25 Rx Only Glycopyrrolate Injection, Usp 1 mg/5 mL (0.2 mg/ml) Not For Use In Newborns Contains Benzyl Alcohol For Im Or Iv Adminisration 25 X 5 mL Multiple Dose Vials (Glycopyrrolate Injection 5)

This text is a description of a medication called Glycopyrrolate that comes in 1 mg per 5 mL doses and is an injection for intramuscular or intravenous use. It is not recommended for use in newborns and contains benzyl alcohol as a preservative. The medication is stored at a controlled room temperature between 20°C to 25°C and is distributed by Hikma Pharmaceuticals USA Inc. The text also includes the NDC number and dosage instructions which are provided in the package insert.*

FDA Label Image

Glycopyrrolate Injection 6

This is a medication called Glycopyrrolate that is available in a single dose vial of 2 mL to be used intramuscularly or intravenously. Each 2 mL vial contains 0.4 mg of Glycopyrrolate with a concentration of 0.2 mg/mL along with benzyl alcohol. It is a prescription drug with the NDC code 0143-9681-01 and is distributed by Hikma. The lot number and expiration date are not available.*

FDA Label Image

Glycopyrrolate Injection 7

This text contains information about how to open the package and the dosage for a certain medication named NDC 0143-9681-25. The medication contains water for injection, USP q.s, Benzyl G|vcopvrr0|ate Alcohol, NF (preservative) 0.9% and pH adjusted, when necessary, with injection USP hydrochloric acid and/or sodium hydroxide. The usual dosage is indicated on the package insert and it is recommended to store at 20° to 25°C (68° to 77°F). The medication is not suitable for use in newborns and it contains benzyl alcohol. The package comes with 25 x 2 mL Single Dose Vials by Hikma Pharmaceuticals USA Inc. located in Berkeley Heights, NJ 07922.*

FDA Label Image

Glycopyrrolate Injection 8

This is a description of a pharmaceutical product with the National Drug Code 0143-9679-01. The product is Water for Injection, USP, and is intended for intramuscular or intravenous use. It contains benzyl alcohol and is not recommended for use in newborns. The usual dosage is specified in the package insert. The solution is administered after dilution with the necessary amounts of hydrochloric acid and/or sodium chloride. The storage temperatures are 20° to 25°C (68° to 77°F). The product comes in a multiple-dose vial of 20 mL and is distributed by Hikma Pharmaceuticals USA Inc., located in Berkeley Heights, NJ. The lot number and expiration date are also included in the label.*

FDA Label Image

Glycopyrrolate Injection 9

This is a description of a medication in a 10-20 ml multiple dose vial, intended for intramuscular or intravenous use. The medication contains Glvcopvrrolate 0.9%, with the pH adjusted as necessary, and is stored at 20°C to 25°C. It is necessary to consult the package insert for the usual dosage instructions. The drug includes Benzyl Alcohol as a preservative and is distributed by Hikma Pharmaceuticals USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.